Clinical Trial Update: A Phase Ib Study of HW211026 Ointment in Patients With Actinic Keratosis. [Phase 1]

View source ↗

Summary

A Phase Ib study of HW211026 ointment for actinic keratosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• HW211026 Ointment

Snippet

Sponsor: Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. | Conditions: Actinic Keratosis (AK) | Phase 1 | Status: RECRUITING